Bendukai Bouey
Stepstone Group Lp
Assets Managed
$207.474M
Holdings
18
Last Quarter
2026 - Q1
Filed Date
2d ago
Growth Rate
11.01%(2Q avg: -0.55%)
Sustained Growth
1 quarters
Portfolio positions
This chart displays the top 10 holdings in Stepstone Group Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 18 positions.
Assets under management
The assets under management (AUM) of Stepstone Group Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 207.474M in assets, with a quarterly growth rate of 11.01% and a 2-quarter average growth rate of -0.55%. The portfolio is managed by Bendukai Bouey, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
KRMN Karman Holdings Inc
| 33.85% | $70.229M 877,320 shares@ $80.05 avg price | |
STUB Stubhub Holdings Inc-class A
| 22.75% | $47.188M 7.562M shares@ $6.24 avg price | |
XNDU Xanadu Quantum Technolo-cl B
| 12.62% | $26.181M 3.418M shares@ $7.67 avg price | New Position |
OKUR Onkure Therapeutics Inc-a
| 5.31% | $11.015M 2.661M shares@ $4.15 avg price | Increased 440.85% |
PATH Uipath Inc - Class A
| 4.84% | $10.023M 902,973 shares@ $11.1 avg price | |
KDK Kodiak Ai Inc
| 4.73% | $9.804M 1.413M shares@ $6.95 avg price | Decreased -0.01% |
TRDA Entrada Therapeutics Inc
| 4.64% | $9.607M 761,277 shares@ $12.63 avg price | |
NAVN Navan Inc-cl A
| 3.09% | $6.407M 483,901 shares@ $13.24 avg price | Increased 13.32% |
PHAT Phathom Pharmaceuticals Inc
| 2.27% | $4.689M 422,085 shares@ $11.11 avg price | |
EIKN Eikon Therapeutics Inc
| 2.02% | $4.183M 395,340 shares@ $10.58 avg price | New Position |
1-10 of 18